Table 3 Multilevel Analysis for Differences between Patients in the Two Cohorts at 3 and 9-Month Follow-up (n = 149)
3-month follow-up Mean (SD) a | Adj. mean differenceb (95% CI) | p-value | 9-month follow-up Mean (SD) a | Adj. mean differenceb (95% CI) | p-value | |||
|---|---|---|---|---|---|---|---|---|
Primary outcome measure | CUC; n = 26 | CPC; n = 75 | n = 147 | CUC; n = 19 | CPC; n = 68 | n = 147 | ||
Dependence in activities of daily living (KATZ-15; range 0-15c) | 5.7 (2.8) | 4.6 (2.4) | −0.51 (−1.60, 0.59) | 0.360 | 5.0 (3.0) | 4.4 (2.9) | −0.14 (− 1.41, 1.12) | 0.862 |
Secondary outcome measures | ||||||||
Extended daily activities (FAI; range 15–60) | 27.4 (9.7) | 31.1 (9.4) | 4.14 (0.86, 7.42) | 0.014† | 29.4 (11.2) | 31.0 (9.4) | 1.84 (−1.58, 5.26) | 0.288 |
Social participation (IPA; range 12–60) | 31.0 (6.2) | 28.9 (6.8) | −1.20 (−4.28, 1.88) | 0.441 | 30.8 (8.0) | 30.8 (8.3) | −0.27 (−4.70, 4.16) | 0.903 |
Psychological well-being (Subscale RAND-36; range 5–30) | 22.8 (5.0) | 23.7 (4.7) | −0.53 (−2.61, 1.54) | 0.610 | 22.8 (6.3) | 22.9 (5.6) | −0.91 (−3.67, 1.94) | 0.529 |
Quality of life (CSAL; range 0–100) | 67.9 (14.1) | 70.7 (9.4) | 4.95 (−2.17, 12.08) | 0.171 | 71.4 (9.2) | 68.9(16.4) | 1.54 (−7.29, 10.37) | 0.730 |